CBSC (Cardiac Biotech Solutions) Land And Improvements : $0.00 Mil (As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Cardiac Biotech Solutions Land And Improvements?

Cardiac Biotech Solutions's land and improvements for the quarter that ended in Sep. 2024 was $0.00 Mil.

Cardiac Biotech Solutions Land And Improvements Historical Data

The historical data trend for Cardiac Biotech Solutions's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiac Biotech Solutions Land And Improvements Chart

Cardiac Biotech Solutions Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Land And Improvements

Cardiac Biotech Solutions Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Land And Improvements	Get a 7-Day Free Trial										-	-	-	-	-

Cardiac Biotech Solutions Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Cardiac Biotech Solutions Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cardiac Biotech Solutions Inc (OTCPK:CBSC) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

10845 Griffith Peak Drive, Suite 200, Las Vegas, NV, USA, 89135

Website

https://www.cbscientificinc.com

Cardiac Biotech Solutions Inc formerly, CB Scientific Inc through its U.S. and international subsidiaries, provides products and services in the ambulatory non-invasive cardiac monitoring space. The FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.